Susan Galbraith, Executive VP, Oncology R&D, AstraZeneca

As­traZeneca on­col­o­gy R&D chief Su­san Gal­braith: 'Y­ou're go­ing to need or­thog­o­nal com­bi­na­tion­s'


Ear­li­er in the week we broad­cast our 4th an­nu­al Eu­ro­pean Bio­phar­ma Sum­mit with a great line­up of top ex­ecs. One of the one-on-one con­ver­sa­tions I set up was with Su­san Gal­braith, the on­col­o­gy re­search chief at As­traZeneca. In a wide-rang­ing dis­cus­sion, Gal­braith re­viewed the can­cer drug pipeline and key trends in­flu­enc­ing de­vel­op­ment work at the phar­ma gi­ant. You can watch the video, above, or stick with the script be­low. — JC

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.